AMNEAL PHARMACT Cash Flow - Annual (NYSE:AMRX)

Add to My Stocks
$19.53 $0.05 (0.26%) AMRX stock closing price Jun 18, 2018 (Closing)
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-469.28M-472.03M38.99M57.35M101.25M55.87M65.49M250.41M50.06M18.7M
Depreciation Depletion Amortization Cash-Flow109.44M88.34M68.63M34.02M36M89.6M18.82M121.32M36.14M47.58M
Net Increase (Decrease) in Assets Liabilities-11.11M-2.43M-70.18M-76.23M-11.04M32.55M-98.92M82.19M-97.25M-1.36M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net455.17M460.71M34.47M17.66M23.72M-71.82M20.96M-204.17M2.89M-0.35M
Net Cash from (used by) Operating Activities
84.22M74.59M71.92M32.81M149.94M106.2M6.35M249.76M-8.15M64.56M
Increase (Decrease) in Prop Plant And Equipment-17.63M-48.04M-25.19M-29.91M-32.78M-66.9M-30.52M-16.26M-13.66M-25.86M
Acquisition Disposition of Subsidiaires-0.12M-585.8M-691.34M-------
Increase (Decrease) in Investments-4.22M-4.75M195.31M26.31M-71.1M85.87M15.48M-197.36M-7.36M58.19M
Other Cash Inflow (Outflow) from Investment Activities12.3M11.5M53.69M-13M-12M-104.76M---0.75M-
Net Cash from (used by) Investment Activities
-9.68M-627.09M-467.53M-16.6M-115.89M-85.78M-15.04M-213.63M-21.78M32.32M
Issuance (Purchase) of Equity Shares1.37M9.23M99.79M11.09M8.21M12.61M14.77M17.72M5.11M-
Issuance (Repayment) of Debt Securities-70M395M600M------12.88M-65.23M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-5.04M-12.45M-178.4M3.31M-4.7M6.53M6.17M--
Net Cash from (used by) Financing Activities
-73.67M391.78M521.38M14.41M8.96M17.31M21.3M23.9M-7.56M-65.07M
Effect of Exchange Rate Changes on Cash---0.29M-0.36M-0.56M-----
Net Change in Cash & Cash Equivalents
1.64M-160.21M125.47M30.26M42.45M37.74M12.62M60.02M-37.5M31.81M
Cash & Equivalents at Beginning of Year180.13M340.35M214.87M184.61M142.16M104.41M91.79M31.77M69.27M37.46M
Cash & Equivalents at Year End181.77M180.13M340.35M214.87M184.61M142.16M104.41M91.79M31.77M69.27M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Key Financial Ratios For AMNEAL PHARMACT Cash Flow